261 related articles for article (PubMed ID: 6426727)
1. [Adjuvant chemotherapy for some common malignant tumors].
Wu YF
Zhonghua Yi Xue Za Zhi; 1983 Oct; 63(10):641-4. PubMed ID: 6426727
[No Abstract] [Full Text] [Related]
2. [US-Japan Cooperative Cancer Research Program--adjuvant and neo-adjuvant chemotherapy].
Ogawa M
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1175-9. PubMed ID: 3566311
[No Abstract] [Full Text] [Related]
3. [Problems in surgical adjuvant therapy].
Taguchi T; Hara N; Nakajima T; Hojo K; Miura S
Gan To Kagaku Ryoho; 1990 May; 17(5):975-91. PubMed ID: 2334177
[No Abstract] [Full Text] [Related]
4. Postsurgical adjuvant chemotherapy: a review.
Diekamp U; Lad TE; McGuire WP
Surg Annu; 1981; 13():31-52. PubMed ID: 7025285
[No Abstract] [Full Text] [Related]
5. What can the clinician expect from the chemotherapy of tumors of the breast, colon, and lung?
Panettiere FJ
J Ark Med Soc; 1980 Oct; 77(5):199-203. PubMed ID: 6448247
[No Abstract] [Full Text] [Related]
6. [Transition of criteria for the determination of efficacy of cancer chemotherapy].
Koyama Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):153-63. PubMed ID: 3942397
[No Abstract] [Full Text] [Related]
7. The systemic chemotherapy of hepatic metastases.
Kemeny N
Semin Oncol; 1983 Jun; 10(2):148-58. PubMed ID: 6346494
[No Abstract] [Full Text] [Related]
8. [Cooperation between the Soviet and the United States oncologists in the field of tumor chemotherapy].
Perevodchikova NI; Komarova LE; Kiselev AK
Vopr Onkol; 1974; 20(12):3-7. PubMed ID: 4446468
[No Abstract] [Full Text] [Related]
9. [Clinical trial of 5'-DFUR against various malignant tumors].
Okumura T
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2365-70. PubMed ID: 2934025
[TBL] [Abstract][Full Text] [Related]
10. [Observations on the antipyretic effect of phenylbutazone in malignant lymphoma and other febrile neoplasms. Preliminary note].
Fica V; Olteanu D; Oprescu S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(6):523-8. PubMed ID: 6136077
[No Abstract] [Full Text] [Related]
11. [The influence of chemotherapy on delayed allergy in patients with malignant tumors].
Rikhe K
Vopr Onkol; 1973; 19(10):50-6. PubMed ID: 4132931
[No Abstract] [Full Text] [Related]
12. Solid-organ malignancy as a risk factor for tuberculosis.
Kim HR; Hwang SS; Ro YK; Jeon CH; Ha DY; Park SJ; Lee CH; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Respirology; 2008 May; 13(3):413-9. PubMed ID: 18399865
[TBL] [Abstract][Full Text] [Related]
13. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors.
Cohen SM; Weiner MJ; Greenspan EM
Cancer Chemother Rep; 1972 Dec; 56(6):751-4. PubMed ID: 4660631
[No Abstract] [Full Text] [Related]
14. An outline of cancer chemotherapy.
Connors TA
Rev Roum Inframicrobiol; 1971; 8(3):135-51. PubMed ID: 5152643
[No Abstract] [Full Text] [Related]
15. [Cytostatic chemotherapy in the treatment of malignant tumors].
Langhammer H; Klemm J; Pabst HW
Arztl Forsch; 1966 Aug; 20(8):393-403. PubMed ID: 6014703
[No Abstract] [Full Text] [Related]
16. [Adjuvant chemotherapy in cancers of the stomach, pancreas and intestine].
Martin F
Bull Cancer; 1984; 71(4):374-6. PubMed ID: 6498350
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy of malignant tumors by arterial approach].
Escó Barón R
Rev Med Univ Navarra; 1983 Mar; 27(1):9-20. PubMed ID: 6669836
[No Abstract] [Full Text] [Related]
18. [Are combinations more effective than monotherapy in the matter of antiocancer chemotherapy?].
Horton J; Olson K
Poumon Coeur; 1968; 24(1):59-62. PubMed ID: 4968016
[No Abstract] [Full Text] [Related]
19. [A clinical study of N-nitrosomethylurea].
Vermel' EM; Korman NP; Milonov BV; Evseenko LS; Orlova RS
Vopr Onkol; 1970 May; 16(5):31-7. PubMed ID: 4915916
[No Abstract] [Full Text] [Related]
20. Modern chemotherapy in solid tumours.
Kaye SB
Q J Med; 1994 Jun; 87(6):319-22. PubMed ID: 8041863
[No Abstract] [Full Text] [Related]
[Next] [New Search]